National device coalition delivering FDA reform proposals to Congress May 11.
This article was originally published in The Gray Sheet
Executive SummaryNATIONAL MEDICAL DEVICE COALITION'S FDA REFORM PROPOSALS will be hand-delivered to key members of Congress May 11, NMDC says. Fifty to 60 industry executives, representing small to mid-sized device manufacturers from around the country, are participating in an NMDC-sponsored "Fly-In" to Washington, D.C., during which coalition members will present the group's ideas for reforming FDA's system of device regulation.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.